Breaking News Instant updates and real-time market news.

QCOM

Qualcomm

$57.39

0.49 (0.86%)

, AAPL

Apple

$157.94

0.09 (0.06%)

09:00
01/03/19
01/03
09:00
01/03/19
09:00

Qualcomm posts bonds to enforce permanent injunction against iPhones in Germany

Qualcomm (QCOM) announced that it has posted security bonds totaling EUR1.34B. The bonds are required for Qualcomm to be able to enforce the remedies ordered by the Court on December 20, 2018, after the Court found that Apple (AAPL) is infringing Qualcomm's patented power savings technology used in smartphones. Apple was ordered to cease the sale, offer for sale and importation for sale of all infringing iPhones in Germany. The Court also ordered Apple to recall infringing iPhones from third party re-sellers in Germany.

QCOM

Qualcomm

$57.39

0.49 (0.86%)

AAPL

Apple

$157.94

0.09 (0.06%)

  • 07

    Jan

  • 07

    Jan

QCOM Qualcomm
$57.39

0.49 (0.86%)

01/03/19
ADAM
01/03/19
NO CHANGE
Target $75
ADAM
Buy
FTC case could lead to settlement between Qualcomm and Apple, says Canaccord
Canaccord analyst T. Michael Walkley said the upcoming FTC case is an important step in the process towards Qualcomm (QCOM) and Apple (AAPL) reaching a licensing settlement. The analyst noted that in a partial summary judgment, it required Qualcomm to license cellular standard-essential patents to the Alliance for Telecommunications Industry Standards, presenting potential risks to its licensing practices. Walkley maintains his Buy rating and $75 price target on Qualcomm shares.
12/24/18
WEDB
12/24/18
NO CHANGE
Target $275
WEDB
Outperform
Wedbush lays out Apple investor 'Christmas wish list' for 2019
Wedbush analyst Daniel Ives said that sentiment about Apple (AAPL) "is as negative as we have seen in many years" with the stock down over 30% since early November, though he "vehemently" disagrees with those who are pricing in a "meaningful apocalyptic iPhone unit deceleration not just for 2019 but possibly for 2020." With Apple investors looking toward 2019, Ives laid out his "Top 10 holiday wish list for Apple investors," which includes FY19 iPhone units shipped topping 200M; China consumer iPhone upgrades for FY19 hitting 30M; settling the Qualcomm (QCOM) patent issue "once and for all"; services business hits revenue over $45B in FY19; more transparency and metrics around the services business; a meaningful acquisition of a major content player; announcing an accelerated buyback program; lowering prices on some OLED iPhone models; the China trade war being settled in early 2019; and Apple announcing a strategic partnership with Tesla (TSLA). Ives keeps an Outperform rating and $275 price target on Apple shares.
12/21/18
ARGS
12/21/18
NO CHANGE
ARGS
Buy
German ruling may increase pressure on Apple to settle with Qualcomm, says Argus
Argus analyst Jim Kelleher said the recent German patent ruling, coupled with an earlier Chinese ruling, could increase pressure on Apple (AAPL) to settle its legal fight with Qualcomm (QCOM), adding that he believes Qualcomm being willing to consider changes to its percentage-of-device-price revenue model is "the one thing that could push a settlement forward." The analyst, who sees it as only a matter of time before this royalty model is adjusted, keeps a Buy rating on Qualcomm shares.
12/21/18
JPMS
12/21/18
NO CHANGE
JPMS
Overweight
JPMorgan sees minimal financial impact to Apple from Germany injunction
JPMorgan analyst Samik Chatterjee sees a minimal financial impact to Apple (AAPL) after the District Court of Munich in Germany issued a permanent injunction against the company relative to the infringement of a Qualcomm (QCOM) hardware patent and has restricted Apple from selling specific iPhones in the country. The analyst estimates that the financial impact of Apple's stop-sale is likely minimal given that Germany accounts for only 3% of its total global shipments. Further, Apple owns only 15 stores in the whole of Germany, Chatterjee tells investors in a research note. He would expect the impact to be less than 1M shipments on an annualized basis. The analyst keeps an Overweight rating on Apple.
AAPL Apple
$157.94

0.09 (0.06%)

01/03/19
NEED
01/03/19
NO CHANGE
Target $66
NEED
Buy
Qorvo price target lowered to $66 from $78 at Needham
Needham analyst N. Quinn Bolton lowered his price target on Qorvo (QRVO) to $66 after the negative Q1 revenue pre-announcement from Apple (AAPL). The analyst believes that the company will be able to achieve its previously guided metrics in the quarter but will then be faced with an inventory correction in Q2 and Q3 amid lower iPhone unit sell-throughs. Bolton also keeps his Buy rating on Qorvo longer term and sees his implied 10-times forward earnings valuation multiple as conservative.
01/03/19
NEED
01/03/19
NO CHANGE
Target $77
NEED
Buy
Skyworks price target lowered to $77 from $99 at Needham
Needham analyst N. Quinn Bolton lowered his price target on Skyworks (SWKS) to $77 after the negative Q1 revenue pre-announcement from Apple (AAPL). The analyst believes that the company will be able to achieve its previously guided metrics in the quarter but will then be faced with an inventory correction in Q2 and Q3 amid lower iPhone unit sell-throughs. Bolton keeps his Buy rating on Skyworks longer term and sees his implied 10-times forward earnings valuation multiple as conservative.
01/03/19
ROTH
01/03/19
NO CHANGE
Target $3
ROTH
Buy
Apple weakness could spill over into Digital Turbine, says Roth Capital
Roth Capital analyst Darren Aftahi says weakness from Apple's (AAPL) negative pre-announcement, citing primarily emerging market weakness and fewer iPhone upgrades, could spill over into Digital Turbine (APPS). The analyst would be a buyer on any material weakness given Digital Turbine has no handset exposure to China and its exposure is to the Android based platform, where handsets tend to skew lower on ASP, in general. Apple weakness could create buying opportunity, he contends. Aftahi reiterates a Buy rating and $3 price target on Digital Turbine's shares.
01/03/19
BMOC
01/03/19
NO CHANGE
Target $153
BMOC
Market Perform
Apple price target lowered to $153 from $213 at BMO Capital
BMO Capital analyst Tim Long lowered his price target on Apple to $153 and kept his Market Perform rating after its disappointing Q1 outlook, saying that the new expectations for revenue is "dramatically lower" than prior forecast. The analyst notes that he has previously expressed caution about the ability of the new iPhone to drive an upgrade cycle but sees the expectations for December quarter results as worse than he anticipated. Long says he will retain his neutral view on Apple shares until he sees signs that its iPhone business is stabilizing.

TODAY'S FREE FLY STORIES

ZTO

ZTO Express

$22.44

0.09 (0.40%)

15:04
11/18/19
11/18
15:04
11/18/19
15:04
Options
ZTO Express options imply 8.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

AMZN

Amazon.com

$1,752.30

14.81 (0.85%)

, SPOT

Spotify

$142.13

-5.22 (-3.54%)

14:59
11/18/19
11/18
14:59
11/18/19
14:59
Hot Stocks
Amazon Music to offer free ad-supported option »

Amazon (AMZN) said in a…

AMZN

Amazon.com

$1,752.30

14.81 (0.85%)

SPOT

Spotify

$142.13

-5.22 (-3.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

LCNB

LCNB Corp.

$17.93

-0.26 (-1.43%)

14:59
11/18/19
11/18
14:59
11/18/19
14:59
Hot Stocks
LCNB Corp. raises dividend 5.88% to 18c per share »

LCNB Corp. declared a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:55
11/18/19
11/18
14:55
11/18/19
14:55
General news
Fed's Rosengren repeated the economy is in a good place »

Fed's Rosengren…

SPOT

Spotify

$142.01

-5.34 (-3.62%)

14:50
11/18/19
11/18
14:50
11/18/19
14:50
Hot Stocks
Spotify debuts 'Soundtrack your Ride' feature to make playlists for road trips »

Over this past weekend,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

DIS

Disney

$148.24

3.61 (2.50%)

14:50
11/18/19
11/18
14:50
11/18/19
14:50
Periodicals
Disney+ accounts of thousands of users hacked, Cheddar says »

Disney+ users have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSB

GlobalSCAPE

$10.14

0.09 (0.90%)

14:50
11/18/19
11/18
14:50
11/18/19
14:50
Hot Stocks
Breaking Hot Stocks news story on GlobalSCAPE »

Globalscape trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$16.49

-0.22 (-1.32%)

14:49
11/18/19
11/18
14:49
11/18/19
14:49
Options
Bilibili options imply 13.3% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

BAP

Credicorp

$210.20

-0.45 (-0.21%)

14:45
11/18/19
11/18
14:45
11/18/19
14:45
Hot Stocks
Credicorp reports testimony of chairman in Peruvian government investigation »

Credicorp announces that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$8.29

-0.03 (-0.36%)

14:45
11/18/19
11/18
14:45
11/18/19
14:45
Options
Overstock com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

GSB

GlobalSCAPE

$10.14

0.09 (0.90%)

14:41
11/18/19
11/18
14:41
11/18/19
14:41
Hot Stocks
GlobalSCAPE announces $3.35 per share special cash dividend, $5M buyback program »

GlobalSCAPE announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$162.37

5.115 (3.25%)

, NTDOY

Nintendo

$0.00

(0.00%)

14:30
11/18/19
11/18
14:30
11/18/19
14:30
Periodicals
Roku rolls out fix after new 'Pokemon' games cause crashing problems, Verge says »

Roku (ROKU) confirmed…

ROKU

Roku

$162.37

5.115 (3.25%)

NTDOY

Nintendo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

FB

Facebook

$197.78

2.71 (1.39%)

14:30
11/18/19
11/18
14:30
11/18/19
14:30
Hot Stocks
Facebook's Oculus Link launches beta to play PC Rift games wired to Quest »

Oculus said in-part in an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

14:28
11/18/19
11/18
14:28
11/18/19
14:28
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

GSB

GlobalSCAPE

$10.13

0.08 (0.80%)

14:26
11/18/19
11/18
14:26
11/18/19
14:26
Hot Stocks
Breaking Hot Stocks news story on GlobalSCAPE »

Globalscape trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CERN

Cerner

$67.76

-0.63 (-0.92%)

14:25
11/18/19
11/18
14:25
11/18/19
14:25
Options
Cerner call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRHC

Tabula Rasa HealthCare

$41.26

-0.83 (-1.97%)

14:25
11/18/19
11/18
14:25
11/18/19
14:25
Conference/Events
Tabula Rasa HealthCare participates in a conference call with Benchmark »

Conference call with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

DNA

Bought by RHHBY

$0.00

(0.00%)

14:23
11/18/19
11/18
14:23
11/18/19
14:23
Conference/Events
Wolfe Research pharma analyst to hold an analyst/industry webcast »

Global Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$28.22

2.08 (7.96%)

14:18
11/18/19
11/18
14:18
11/18/19
14:18
Recommendations
MorphoSys analyst commentary  »

MorphoSys B-MIND futility…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/18/19
11/18
14:17
11/18/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/18/19
11/18
14:16
11/18/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$28.22

2.08 (7.96%)

14:14
11/18/19
11/18
14:14
11/18/19
14:14
Hot Stocks
MorphoSys says tafasitamab B-MIND study successfully passed futility analysis »

Earlier, MorphoSys…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

DISCA

Discovery

$30.74

1.03 (3.47%)

14:03
11/18/19
11/18
14:03
11/18/19
14:03
Hot Stocks
Discovery rises after Malone buys $75M worth of stock »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$196.73

1.66 (0.85%)

14:01
11/18/19
11/18
14:01
11/18/19
14:01
Options
Call volume jumps in Facebook as shares and implied volatility lift »

Call volume jumps in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

ABMD

Abiomed

$190.75

-32.48 (-14.55%)

13:54
11/18/19
11/18
13:54
11/18/19
13:54
Hot Stocks
Abiomed falls after studies question Impella heart device at AHA 2019 meeting »

In a story out over the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.